Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make up lost ground in the race to develop a new generation of “immunotherapy” medicines that turn the body into a weapon against tumours.
輝瑞(Pfizer)計劃明年在人體上測試綜合使用三種新型抗癌藥的療效。這家美國藥企正尋求在研發新一代“免疫療法”藥物的競賽中收復失地，這類藥物能把人體變成對抗腫瘤的武器。
您已閱讀14%（336字），剩余86%（2077字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。